GSA Capital Partners’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
OCAM
HCL
VCM
QF
PM
GI
GSA Capital Partners's ATEX Position: Q1 2026 in Review
GSA Capital Partners sold out of Anterix (ATEX) in Q1 2026, closing a stake of 72,976 shares — an estimated $1.59M sold.
GSA Capital Partners first reported a position in ATEX in Q4 2016 and held it in 9 quarters. The position peaked at $2.32M in Q2 2021. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.
- GSA Capital Partners reported no remaining Anterix position as of Q1 2026 after selling out during the quarter.
- GSA Capital Partners sold 72,976 Anterix shares in Q1 2026, an estimated $1.59M.
- GSA Capital Partners first reported a position in Anterix in Q4 2016 and held it in 9 quarters.
- GSA Capital Partners's Anterix position peaked at $2.32M in Q2 2021.
- 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.
Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.